Precautions for Bevacizumab for Lung Adenocarcinoma include a possible increased risk of pulmonary hemorrhage, gastrointestinal perforations and fistulas, and should be used as directed by a physician.
Bevacizumab is commonly available in injectable form, and the drug insert states that the precautions for this product have the potential to increase the risk of gastrointestinal perforation and fistula, pulmonary hemorrhage, hypertension, arterial thromboembolism, venous thromboembolism, and neutropenia. It can cause serious eye infections, aggravate congestive heart failure, and adversely affect wound healing.
Bevacizumab is used for metastatic colorectal cancer, non-small cell lung cancer. Adverse effects of this product can be seen in leukopenia, neutropenia, thrombocytopenia, peripheral sensory neuropathy, hypertension. It is contraindicated for those who are allergic to the drug. The drug should be used under medical supervision.